Gene Green: “Thank you for holding the hearing.”

Eight years ago, Congress passed the Affordable Care Act to address the HHS Office of Inspector General reports of drug manufacturers overcharging 340B drugs.

Patients and families deserve to have their elected officials respond to their needs. The 21st Century Cures was written to do just that.

If the administration cares about accountability for 340B, perhaps they should start with implementing the delayed regulatory guidance program.

The promise of the 21st Century Cures Act is to advance the discovery and development of new treatments and cures through increased research and an improved drug approval process.